How Real-World Data Can Help Us Better Prepare for the Next Pandemic
In this Scientific American article, Joseph Menzin, PhD and Peter Neumann, ScD discuss how real-world data can help us better prepare for a future pandemic. The authors highlight how rapid testing is important, but that there’s a wealth of other information that could have offered us quicker insight into the spread of COVID. Menzin and […]
5 Steps To Prepare For A Third-Party Drug Price Evaluation
In this Life Science Leader article, Matt Sussman discusses important steps to take when preparing for a third party drug price evaluation. Sussman notes that determining fair and reasonable drug prices in the U.S. has long been a source of debate as the U.S. has lacked consistent, independent economic analysis to assess the value of […]
The Pressure To Publish Rapidly: The Risks Vs. Rewards Of Fast-Tracked COVID-19 Studies
In this article with Health IT Outcomes, Joseph Menzin discusses fast-tracked COVID-19 studies, noting that with the fear surrounding the pandemic and the pressure to both understand the disease and find a cure, it’s not surprising the publication of scientific papers is being rushed. However, there are limitations of these fast-tracked studies that we must consider […]
Pandemic Pricing: The Risks and Rewards of Fast-Tracking Value-Based Drug Evaluations
Matt Sussman, VP of Modeling & Strategy at Panalgo, discusses the risks and rewards of fast-tracking drug price evaluations in the COVID era in this Pharmacy Times article. He notes that ICER’s expedited evaluation of remdesivir raises some questions related to value-based pricing evaluations that shouldn’t be overlooked. Read the full article for Sussman’s view […]
Gaining Rapid Understanding of COVID-19 Through a Real-world Data Lens
In this Healthcare IT Today article, Joseph Menzin, PhD, dives into the COVID-19 pandemic and the need for more timely data in the course of emergency situations. The success of those efforts will largely depend on gleaning information from the real-world data (RWD) being collected on COVID-19 patients. Joseph’s report compares the underlying conditions most […]
The Future of Healthcare: “We need to recognize that health outcomes are not just about medical care”, With Dr. Joseph Menzin of Boston Health Economics
Panalgo CEO, Joseph Menzin, PhD, gets interviewed as a leader in the healthcare industry. Joe talks the founding of BHE and his 30 years of experience in the fields of outcomes research and healthcare data analytics, as well as where he sees the industry going in the future. Check out the full interview here.